These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

147 related articles for article (PubMed ID: 17686853)

  • 1. No evidence for consistent virus-specific immunity in simian immunodeficiency virus-exposed, uninfected rhesus monkeys.
    Letvin NL; Rao SS; Dang V; Buzby AP; Korioth-Schmitz B; Dombagoda D; Parvani JG; Clarke RH; Bar L; Carlson KR; Kozlowski PA; Hirsch VM; Mascola JR; Nabel GJ
    J Virol; 2007 Nov; 81(22):12368-74. PubMed ID: 17686853
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Deep transcriptional sequencing of mucosal challenge compartment from rhesus macaques acutely infected with simian immunodeficiency virus implicates loss of cell adhesion preceding immune activation.
    Barrenas F; Palermo RE; Agricola B; Agy MB; Aicher L; Carter V; Flanary L; Green RR; McLain R; Li Q; Lu W; Murnane R; Peng X; Thomas MJ; Weiss JM; Anderson DM; Katze MG
    J Virol; 2014 Jul; 88(14):7962-72. PubMed ID: 24807713
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Selective induction of protective MHC class I-restricted CTL in the intestinal lamina propria of rhesus monkeys by transient SIV infection of the colonic mucosa.
    Murphey-Corb M; Wilson LA; Trichel AM; Roberts DE; Xu K; Ohkawa S; Woodson B; Bohm R; Blanchard J
    J Immunol; 1999 Jan; 162(1):540-9. PubMed ID: 9886431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional simian immunodeficiency virus Gag-specific CD8+ intraepithelial lymphocytes in the mucosae of SIVmac251- or simian-human immunodeficiency virus KU2-infected macaques.
    Stevceva L; Moniuszko M; Alvarez X; Lackner AA; Franchini G
    Virology; 2004 Feb; 319(2):190-200. PubMed ID: 14980480
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protection against mucosal SIVsm challenge in macaques infected with a chimeric SIV that expresses HIV type 1 envelope.
    Quesada-Rolander M; Mäkitalo B; Thorstensson R; Zhang YJ; Castaños-Velez E; Biberfeld G; Putkonen P
    AIDS Res Hum Retroviruses; 1996 Jul; 12(11):993-9. PubMed ID: 8827215
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Differential effects of simian immunodeficiency virus infection on immune inductive and effector sites in the rectal mucosa of rhesus macaques.
    Vajdy M; Veazey RS; Knight HK; Lackner AA; Neutra MR
    Am J Pathol; 2000 Aug; 157(2):485-95. PubMed ID: 10934152
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization with virion-derived glycoprotein 130 from HIV-2 or SIV protects macaques against challenge virus grown in human or simian cells or prepared ex vivo.
    Stahl-Hennig C; Coulibaly C; Petry H; Voss G; Dittmer U; Bodemer W; Makoschey B; Jurkiewicz E; Lüke W; Hunsmann G
    AIDS Res Hum Retroviruses; 1994; 10 Suppl 2():S27-32. PubMed ID: 7865316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Low-dose mucosal simian immunodeficiency virus infection restricts early replication kinetics and transmitted virus variants in rhesus monkeys.
    Liu J; Keele BF; Li H; Keating S; Norris PJ; Carville A; Mansfield KG; Tomaras GD; Haynes BF; Kolodkin-Gal D; Letvin NL; Hahn BH; Shaw GM; Barouch DH
    J Virol; 2010 Oct; 84(19):10406-12. PubMed ID: 20686016
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Th-1-type cytotoxic CD8+ T-lymphocyte responses to simian immunodeficiency virus (SIV) are a consistent feature of natural SIV infection in sooty mangabeys.
    Wang Z; Metcalf B; Ribeiro RM; McClure H; Kaur A
    J Virol; 2006 Mar; 80(6):2771-83. PubMed ID: 16501086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Passive immunization of rhesus macaques against SIV infection and disease.
    Gardner M; Rosenthal A; Jennings M; Yee J; Antipa L; Robinson E
    AIDS Res Hum Retroviruses; 1995 Jul; 11(7):843-54. PubMed ID: 7546912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Repeated exposure of rhesus macaques to low doses of simian immunodeficiency virus (SIV) did not protect them against the consequences of a high-dose SIV challenge.
    Dittmer U; Stahl-Hennig C; Coulibaly C; Nisslein T; Lüke W; Fuchs D; Bodemer W; Petry H; Hunsmann G
    J Gen Virol; 1995 Jun; 76 ( Pt 6)():1307-15. PubMed ID: 7782761
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Virus-specific cellular immune correlates of survival in vaccinated monkeys after simian immunodeficiency virus challenge.
    Sun Y; Schmitz JE; Buzby AP; Barker BR; Rao SS; Xu L; Yang ZY; Mascola JR; Nabel GJ; Letvin NL
    J Virol; 2006 Nov; 80(22):10950-6. PubMed ID: 16943292
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mucosal exposure to subinfectious doses of SIV primes gut-associated antibody-secreting cells and T cells: lack of enhancement by nonneutralizing antibody.
    Polyanskaya N; Bergmeier LA; Sharpe SA; Cook N; Leech S; Hall G; Dennis M; ten Haaft P; Heeney J; Manca F; Lehner T; Cranage MP
    Virology; 2001 Jan; 279(2):527-38. PubMed ID: 11162808
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protection of SIVmac-infected macaque monkeys against superinfection by a simian immunodeficiency virus expressing envelope glycoproteins of HIV type 1.
    Dunn CS; Hurtrel B; Beyer C; Gloeckler L; Ledger TN; Moog C; Kieny MP; Mehtali M; Schmitt D; Gut JP; Kirn A; Aubertin AM
    AIDS Res Hum Retroviruses; 1997 Jul; 13(11):913-22. PubMed ID: 9223407
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Vectored Gag and Env but not Tat show efficacy against simian-human immunodeficiency virus 89.6P challenge in Mamu-A*01-negative rhesus monkeys.
    Liang X; Casimiro DR; Schleif WA; Wang F; Davies ME; Zhang ZQ; Fu TM; Finnefrock AC; Handt L; Citron MP; Heidecker G; Tang A; Chen M; Wilson KA; Gabryelski L; McElhaugh M; Carella A; Moyer C; Huang L; Vitelli S; Patel D; Lin J; Emini EA; Shiver JW
    J Virol; 2005 Oct; 79(19):12321-31. PubMed ID: 16160159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immune and Genetic Correlates of Vaccine Protection Against Mucosal Infection by SIV in Monkeys.
    Letvin NL; Rao SS; Montefiori DC; Seaman MS; Sun Y; Lim SY; Yeh WW; Asmal M; Gelman RS; Shen L; Whitney JB; Seoighe C; Lacerda M; Keating S; Norris PJ; Hudgens MG; Gilbert PB; Buzby AP; Mach LV; Zhang J; Balachandran H; Shaw GM; Schmidt SD; Todd JP; Dodson A; Mascola JR; Nabel GJ
    Sci Transl Med; 2011 May; 3(81):81ra36. PubMed ID: 21543722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Correlation of vaccine-elicited systemic and mucosal nonneutralizing antibody activities with reduced acute viremia following intrarectal simian immunodeficiency virus SIVmac251 challenge of rhesus macaques.
    Hidajat R; Xiao P; Zhou Q; Venzon D; Summers LE; Kalyanaraman VS; Montefiori DC; Robert-Guroff M
    J Virol; 2009 Jan; 83(2):791-801. PubMed ID: 18971271
    [TBL] [Abstract][Full Text] [Related]  

  • 18. HIV-1 vaccines based on replication-competent Tiantan vaccinia protected Chinese rhesus macaques from simian HIV infection.
    Liu Q; Li Y; Luo Z; Yang G; Liu Y; Liu Y; Sun M; Dai J; Li Q; Qin C; Shao Y
    AIDS; 2015 Mar; 29(6):649-58. PubMed ID: 25849828
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular immune response of rhesus monkeys infected with a partially attenuated nef deletion mutant of the simian immunodeficiency virus.
    Dittmer U; Nisslein T; Bodemer W; Petry H; Sauermann U; Stahl-Hennig C; Hunsmann G
    Virology; 1995 Oct; 212(2):392-7. PubMed ID: 7571408
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunohistochemical studies of productive rhesus cytomegalovirus infection in rhesus monkeys (Macaca mulatta) infected with simian immunodeficiency virus.
    Kuhn EM; Stolte N; Mätz-Rensing K; Mach M; Stahl-Henning C; Hunsmann G; Kaup FJ
    Vet Pathol; 1999 Jan; 36(1):51-6. PubMed ID: 9921756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.